Why choose Rubius Therapeutics?
Why choose Rubius Therapeutics?
At Rubius Therapeutics, we are ushering in a new era in cellular medicine—an era in which we aim to transform the treatment of cancer and autoimmune diseases.
What are the three types of biodiversity?
The three types of Biodiversity are: 1 Species Diversity 2 Ecosystem Diversity 3 Genetic Diversity
Who is the COO of Rubius?
Dannielle Appelhans joined Rubius as Chief Operating Officer in August of 2021, bringing experience in gene therapy, strategy, manufacturing, supply chain and operations. As COO, she oversees corporate strategy and technical operations for Rubius.
What are the 4 types of diversity in the workplace?
The four diversity type dimensions are Internal, External, Organizational, and World View. Internal Diversity Types in the Workplace Internal Diversity Types are Diversity types that are related to a person that they are born into, they are things that none of us can change (most of the cases).
Who is Rubius Therapeutics’s new CFO?
Pepe joined Rubius Therapeutics as Chief Financial Officer in September 2020. Pepe previously served as the Chief Financial Officer of Radius Health, a biopharmaceutical company developing and commercializing endocrine therapeutics.
Who is Rubius’s new oncologist?
A trained oncologist and immunologist, Dr. Coughlin joins Rubius from Tmunity Therapeutics, Inc., where she served as chief medical officer and was responsible for the development of Tmunity’s CAR-T and TCR-T cellular therapy pipeline across preclinical, regulatory and clinical development activities.
Who are the new manufacturing executives at Rubius?
Prior to Merck, Spencer held various process development and manufacturing roles at Genentech, Genencor and Novo Nordisk. Bryan Gillis joined Rubius in August 2018 as the Site Head of our manufacturing facility in Smithfield, RI, and in August of 2019 was named Vice President of Manufacturing.